Nanoparticle drug delivery

Global Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems Market Report 2020-2025 with Profiles of Bristol-Myers Squibb Co., GSK, Hofmann-La Roche, Merck & Co., and Novartis

Retrieved on: 
Monday, January 25, 2021
Drug delivery, Medical equipment, Nanomedicine, Health sciences, Medical research, Life sciences, Solid lipid nanoparticle, Emerging technologies, Nanoparticle drug delivery

DUBLIN, Jan. 25, 2021 /PRNewswire/ -- The "Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 25, 2021 /PRNewswire/ -- The "Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems" report has been added to ResearchAndMarkets.com's offering.
  • The report includes an analysis of leading and emerging drug products for each nanoparticle type.
  • The most rapid advances have been made in the application of nanoparticles in drug research and development, drug product formulation, and development of novel drug delivery systems using nanoparticle carriers.
  • Drug formulation and delivery are attracting new players in Europe, and this in turn will contribute to the market's growth.

Global COVID-19 Drug Delivery Devices Market Outlook to 2027: Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 29, 2020
Health, General Health, Drug delivery, Medical equipment, Life sciences, Biotechnology, Health sciences, Nanoparticle drug delivery

The "COVID-19 Drug Delivery Devices - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "COVID-19 Drug Delivery Devices - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.
  • However, high manufacturing cost of COVID-19 drug delivery devices is restraining the market growth.
  • COVID-19 Drug Delivery Devices are engineered technologies for efficient drug delivery and/or release of therapeutic agents in the circulatory system and drug movement through cells and tissues for the prevention of COVID-19.
  • Drug delivery devices control the rate at which a drug is released and the location in the body where it is released.

Controlled Release Drug Delivery Market Size Worth $69.8 Billion by 2027: Grand View Research, Inc.

Retrieved on: 
Thursday, March 19, 2020
Pharmacology, Health sciences, Pharmaceutical sciences, Pharmacokinetics, Dosage forms, Modified-release dosage, Drug delivery, Medicinal chemistry, Nanoparticle drug delivery, Targeted drug delivery

The benefits associated with controlled release drug delivery systems, such as increased therapeutic efficacy, less side effects, and low treatment cost are the factors driving the market growth.

Key Points: 
  • The benefits associated with controlled release drug delivery systems, such as increased therapeutic efficacy, less side effects, and low treatment cost are the factors driving the market growth.
  • For instance, controlled release drug delivery system has enabled delivery of even large and complex molecules such as DNA/RNA, proteins and polypeptides.
  • Controlled release of drug delivery systems can be altered according to required dosage over a specific period of time.
  • Grand View Research has segmented the global controlled release drug delivery market on the basis of technology, release mechanism, application, and region:
    Controlled Release Drug Delivery Technology Outlook (Revenue, USD Million, 2016 - 2027)

Controlled Release Drug Delivery Market Size Worth $69.8 Billion by 2027: Grand View Research, Inc.

Retrieved on: 
Thursday, March 19, 2020
Pharmacology, Health sciences, Pharmaceutical sciences, Pharmacokinetics, Dosage forms, Modified-release dosage, Drug delivery, Medicinal chemistry, Nanoparticle drug delivery, Targeted drug delivery

The benefits associated with controlled release drug delivery systems, such as increased therapeutic efficacy, less side effects, and low treatment cost are the factors driving the market growth.

Key Points: 
  • The benefits associated with controlled release drug delivery systems, such as increased therapeutic efficacy, less side effects, and low treatment cost are the factors driving the market growth.
  • For instance, controlled release drug delivery system has enabled delivery of even large and complex molecules such as DNA/RNA, proteins and polypeptides.
  • Controlled release of drug delivery systems can be altered according to required dosage over a specific period of time.
  • Grand View Research has segmented the global controlled release drug delivery market on the basis of technology, release mechanism, application, and region:
    Controlled Release Drug Delivery Technology Outlook (Revenue, USD Million, 2016 - 2027)

Growing Demand for Novel Drug Delivery Technologies that Allow Medication to Cross the Blood Brain Barrier

Retrieved on: 
Monday, January 13, 2020
Branches of biology, Organ systems, Pharmacokinetics, Health sciences, Nanotechnology, Animal physiology, Blood–brain barrier, Central nervous system, Neurology, Nanoparticle, Nanobiotechnology, Nanoparticle drug delivery

The demand for novel drug delivery technology that allows medication to cross the blood brain barrier has been steadily growing.

Key Points: 
  • The demand for novel drug delivery technology that allows medication to cross the blood brain barrier has been steadily growing.
  • Moreover, facilitation of drug delivery and biological therapy for brain cancer across blood brain barrier is one of the important applications of nanobiotechnology.
  • Hence, growing use of nanobiotechnology-based drug delivery for brain tumors is also driving the market.With few challenges faced by nanoparticles-based drug delivery, the ongoing research is expected to present progress in the drug delivery.
  • One of the major advantages of NP-based drug delivery technology is that it overcomes the blood brain barrier limiting property of therapeutic drug module.

Growing Demand for Novel Drug Delivery Technologies that Allow Medication to Cross the Blood Brain Barrier

Retrieved on: 
Monday, January 13, 2020
Branches of biology, Organ systems, Pharmacokinetics, Health sciences, Nanotechnology, Animal physiology, Blood–brain barrier, Central nervous system, Neurology, Nanoparticle, Nanobiotechnology, Nanoparticle drug delivery

The demand for novel drug delivery technology that allows medication to cross the blood brain barrier has been steadily growing.

Key Points: 
  • The demand for novel drug delivery technology that allows medication to cross the blood brain barrier has been steadily growing.
  • Moreover, facilitation of drug delivery and biological therapy for brain cancer across blood brain barrier is one of the important applications of nanobiotechnology.
  • Hence, growing use of nanobiotechnology-based drug delivery for brain tumors is also driving the market.With few challenges faced by nanoparticles-based drug delivery, the ongoing research is expected to present progress in the drug delivery.
  • One of the major advantages of NP-based drug delivery technology is that it overcomes the blood brain barrier limiting property of therapeutic drug module.

Drug Delivery in Cancer: Technologies, Companied and Markets, 2018-2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 9, 2019
Pharmaceutical, Health, Oncology, Health sciences, Health, Medicine, Medicinal chemistry, Oncology, Drug discovery, Pharmacokinetics, Targeted drug delivery, Liposome, Drug delivery, Chemotherapy, Nanoparticle drug delivery

Drug delivery remains a challenge in the management of cancer.

Key Points: 
  • Drug delivery remains a challenge in the management of cancer.
  • Cancer drug delivery is no longer simply wrapping up cancer drugs in a new formulation for different routes of delivery.
  • These may be injected into the arterial circulation and guided to the tumor by magnetic field for targeted drug delivery.
  • Encapsulating anticancer drugs in liposomes enables targeted drug delivery to tumor tissues and prevents damage to the normal surrounding tissues.

KING SKYFRONT, Japan Publishes the September 2019 Issue of Kawasaki SkyFront i-Newsletter

Retrieved on: 
Wednesday, September 11, 2019
Health sciences, Medicine, Health, Oncology, Nanoparticle drug delivery, Nanoparticles, RNAi nanoparticles to target cancer

It was developed in the United States in the middle of the 90's, and many technological improvements since then.

Key Points: 
  • It was developed in the United States in the middle of the 90's, and many technological improvements since then.
  • Now the number of applications for gene therapy is increasing compared to cell therapy and regenerative medicine in the United States.
  • Due to their unstable naturein vivo, nucleic acid drugs are often encapsulated within nanoparticles before injecting into the body.
  • This nanoparticle formulation, however, has the drawback of inaccessibility to intractable tumor tissues, including fibrotic pancreatic cancer and brain tumor.

KING SKYFRONT, Japan Publishes the September 2019 Issue of Kawasaki SkyFront i-Newsletter

Retrieved on: 
Wednesday, September 11, 2019
Health sciences, Medicine, Health, Oncology, Nanoparticle drug delivery, Nanoparticles, RNAi nanoparticles to target cancer

It was developed in the United States in the middle of the 90's, and many technological improvements since then.

Key Points: 
  • It was developed in the United States in the middle of the 90's, and many technological improvements since then.
  • Now the number of applications for gene therapy is increasing compared to cell therapy and regenerative medicine in the United States.
  • Due to their unstable naturein vivo, nucleic acid drugs are often encapsulated within nanoparticles before injecting into the body.
  • This nanoparticle formulation, however, has the drawback of inaccessibility to intractable tumor tissues, including fibrotic pancreatic cancer and brain tumor.

Gold Nanoparticles Market: Worldwide Growth, Trends, and Forecasts 2019-2024 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 12, 2019
Technology, Nanotechnology, Health, Other Health, Chemotherapy, Gold nanoparticles in chemotherapy, Colloidal gold, Nanoparticle, Volatility, Nanoparticles, Nanoparticle drug delivery, Silver nanoparticle

The global gold nanoparticles market is expected to record a CAGR of over 10% during the forecast period of 2019-2024.

Key Points: 
  • The global gold nanoparticles market is expected to record a CAGR of over 10% during the forecast period of 2019-2024.
  • Volatility in the price of gold is expected to hinder the growth of the market studied.
  • Targeted drug delivery segment represents one of the largest application bases for the gold nanoparticles market.
  • This is expected to result in increasing the stability of gold nanoparticles in different physiological conditions and provide a multiformity of combinations on gold nanoparticles.